Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 3, 1997

View Archived Issues

Genzyme Tissue Repair: Q3 1997 highlights

Genzyme Transgenics: Q3 1997 highlights

Celtrix: Q2 1997 highlights

Penederm: Q3 and nine-month 1997 highlights

Anika: Q3 1997 highlights

ImmuCell: Q3 1997 highlights

Laminin-like peptides available for licensing from NIH

New chemical candidate for treating cocaine addiction

Oxazolidinone antibacterial agents prepared at P&U

Merck KGaA reports two new series of ET antagonists

Samjin develops nucleosides for HIV

Vasopressin V1a receptor antagonists claimed for obsessive-compulsive disorder

New orally active thrombin inhibitors from Merck & Co.

nAChR ligands prepared at Astra

Clinical data reported for Actiq

Phase II results promising for E-047/1 following CABG

Effect of AMPA antagonist GYKI-52466 on oxygen balance in ischemic cortex

Clevidipine lowers MAC of anesthetic in animal study

Promising interim safety and efficacy data reported for Gd-Tex

Pharmacokinetics of anti-CD11b MAb in patients undergoing aneurysm repair

Initial results show Ethyol effective in reducing radiation-induced xerostomia

Human safety, immunogenicity and pharmacokinetics reported for h5G1.1-scFV

U.K. launch for Malarone, a potent new antimalarial combination

Genzyme General and Acadia enter drug discovery collaboration

Grant supports p53 gene research at The Wistar Institute

FibroGen granted license to Zeneca antifibrotic compounds

Inhibition of human pancreatic cancer invasion and metastasis by serine protease inhibitor

Pamidronate for preventing glucocorticoid-induced osteoporosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...